Patent foramen ovale transcatheter closure device thrombosis

被引:26
作者
Nkomo, VT
Theuma, P
Maniu, CV
Chandrasekaran, K
Miller, FA
Schaff, HV
Petty, GW
Miller, TD
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Internal Med, Rochester, MN USA
[3] Mayo Clin, Div Cardiovasc Surg, Rochester, MN USA
[4] Mayo Clin, Dept Neurol, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
D O I
10.4065/76.10.1057
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of patent foramen ovale (PFO) in patients with cryptogenic stroke (stroke of unknown cause) remains controversial, although an association seems likely in younger patients with atrial septal aneurysms and PFO. The mechanism of cryptogenic stroke in these patients is presumed to be paradoxical embolism via right-to-left shunt across the PFO. The available options for treatment include medical therapy with antiplatelet or anticoagulant therapy or closure of the PFO surgically or with use of transcatheter PFO closure devices. We describe 2 cases of bilateral device thrombosis associated with use of a transcatheter PFO closure device (CardioSEAL). To our knowledge, only I other case of thrombosis associated with use of this device has been reported.
引用
收藏
页码:1057 / 1061
页数:5
相关论文
共 39 条
[1]   Surgical removal of atrial septal defect occlusion system-devices [J].
Bohm, J ;
Bittigau, K ;
Kohler, F ;
Baumann, G ;
Konertz, W .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 12 (06) :869-872
[2]   TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE AFTER PRESUMED PARADOXICAL EMBOLISM [J].
BRIDGES, ND ;
HELLENBRAND, W ;
LATSON, L ;
FILIANO, J ;
NEWBURGER, JW ;
LOCK, JE .
CIRCULATION, 1992, 86 (06) :1902-1908
[3]  
Butera G, 2001, Ital Heart J, V2, P115
[4]  
Carminati M, 2000, CARDIOL YOUNG, V10, P519
[5]   TRANSESOPHAGEAL ECHOCARDIOGRAPHY AND CAROTID ULTRASOUND IN PATIENTS WITH CEREBRAL-ISCHEMIA - PREVALENCE OF FINDINGS AND RECURRENT STROKE RISK [J].
COMESS, KA ;
DEROOK, FA ;
BEACH, KW ;
LYTLE, NJ ;
GOLBY, AJ ;
ALBERS, GW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (07) :1598-1603
[6]   SUPPRESSION OF HEMOSTATIC SYSTEM ACTIVATION BY ORAL ANTICOAGULANTS IN THE BLOOD OF PATIENTS WITH THROMBOTIC DIATHESES [J].
CONWAY, EM ;
BAUER, KA ;
BARZEGAR, S ;
ROSENBERG, RD .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (06) :1535-1544
[7]   Risk of venous thromboembolism in users of hormone replacement therapy [J].
Daly, E ;
Vessey, MP ;
Hawkins, MN ;
Carson, JL ;
Gough, P ;
Marsh, S .
LANCET, 1996, 348 (9033) :977-980
[8]   Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder [J].
Dhillon, R ;
Thanopoulos, B ;
Tsaousis, G ;
Triposkiadis, F ;
Kyriakidis, M ;
Redington, A .
HEART, 1999, 82 (05) :559-562
[9]   Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism [J].
Ende, DJ ;
Chopra, PS ;
Rao, PS .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (02) :233-236
[10]  
*FOOD DRUG ADM, 2001, CARD SEPT OCCL SYST